[Federal Register Volume 85, Number 1 (Thursday, January 2, 2020)]
[Rules and Regulations]
[Pages 8-10]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-28005]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services

42 CFR Parts 403, 409, 410, 411, 414, 415, 416, 418, 424, 425, 489, 
and 498

[CMS-1715-CN]
RIN 0938-AT72


Medicare Program; CY 2020 Revisions to Payment Policies Under the 
Physician Fee Schedule and Other Changes to Part B Payment Policies; 
Medicare Shared Savings Program Requirements; Medicaid Promoting 
Interoperability Program Requirements for Eligible Professionals; 
Establishment of an Ambulance Data Collection System; Updates to the 
Quality Payment Program; Medicare Enrollment of Opioid Treatment 
Programs and Enhancements to Provider Enrollment Regulations Concerning 
Improper Prescribing and Patient Harm; and Amendments to Physician 
Self-Referral Law Advisory Opinion Regulations Final Rule; and Coding 
and Payment for Evaluation and Management, Observation and Provision of 
Self-Administered Esketamine Interim Final Rule; Correction

AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.

ACTION: Final rule; correction.

-----------------------------------------------------------------------

SUMMARY: This document corrects technical errors in the final rule that 
appeared in the November 15, 2019 Federal Register entitled, ``Medicare 
Program; CY 2020 Revisions to Payment Policies Under the Physician Fee 
Schedule and Other Changes to Part B Payment Policies; Medicare Shared 
Savings Program Requirements; Medicaid Promoting Interoperability 
Program Requirements for Eligible Professionals; Establishment of an 
Ambulance Data Collection System; Updates to the Quality Payment 
Program; Medicare Enrollment of Opioid Treatment Programs and 
Enhancements to Provider Enrollment Regulations Concerning Improper 
Prescribing and Patient Harm; and Amendments to Physician Self-Referral 
Law Advisory Opinion Regulations Final Rule; and Coding and Payment for 
Evaluation and Management, Observation and Provision of Self-
Administered Esketamine Interim Final Rule'' (referred to hereafter as 
the ``CY 2020 PFS final rule'').

DATES: This correcting document is effective January 1, 2020.

[[Page 9]]


FOR FURTHER INFORMATION CONTACT: Terri Plumb, (410) 786-4481, Gaysha 
Brooks, (410) 786-9649, or Annette Brewer (410) 786-6580.

SUPPLEMENTARY INFORMATION:

I. Background

    In FR Doc. 2019-24086 of November 15, 2019, the CY 2020 PFS final 
rule (84 FR 62568), there were technical errors that are identified and 
corrected in this correcting document. These corrections are effective 
and applicable beginning January 1, 2020.

II. Summary of Errors

A. Summary of Errors in the Preamble

    On page 62568 of the CY 2020 PFS final rule, under DATES, we 
inadvertently omitted the applicability date for certain provisions, 
consistent with and as described in section II.P. of the final rule, 
Payment for Evaluation and Management Services.
    On page 62699, we inadvertently included language that we intended 
to delete.
    On page 62910, we inadvertently included the word ``levels''.
    On page 62932, we inadvertently stated incorrectly that the lone 
amendment to our regulation at Sec.  424.535 was the addition of 
paragraph (a)(22).
    On page 62972, third column, last paragraph, lines 20 through 21, 
we inadvertently omitted language.
    On page 62973, first column, first paragraph, lines 4 through 7, we 
inadvertently included certain language and inadvertently omitted other 
language.

B. Summary of Errors in Regulations Text

    On page 63185, we inadvertently omitted language in the amendatory 
instruction.

C. Summary of Errors in the Addenda

    On page 63205, due to a typographical error, language was 
inadvertently omitted in the table title for Table Group A, the title 
is incorrect.
    On page 63212, due to a typographical error, language was 
inadvertently omitted in the table title for Table Group AA, the title 
is incorrect.
    On page 63438, the last sentence of Table D.12 contains a 
typographical error.
    On page 63516, the Activity ID entry contains a typographical 
error.
    On pages 63539 through 63563, Appendix 2 was inadvertently included 
twice.

III. Waiver of Proposed Rulemaking and Delay in Effective Date

    Under 5 U.S.C. 553(b) of the Administrative Procedure Act (the 
APA), the agency is required to publish a notice of the proposed rule 
in the Federal Register before the provisions of a rule take effect. 
Similarly, section 1871(b)(1) of the Social Security Act (the Act) 
requires the Secretary to provide for notice of the proposed rule in 
the Federal Register and provide a period of not less than 60 days for 
public comment. In addition, section 553(d) of the APA and section 
1871(e)(1)(B)(i) of the Act mandate a 30-day delay in effective date 
after issuance or publication of a rule. Sections 553(b)(B) and 
553(d)(3) of the APA provide for exceptions from the APA notice and 
comment, and delay in effective date requirements; in cases in which 
these exceptions apply, sections 1871(b)(2)(C) and 1871(e)(1)(B)(ii) of 
the Act provide exceptions from the notice and 60-day comment period 
and delay in effective date requirements of the Act as well. Section 
553(b)(B) of the APA and section 1871(b)(2)(C) of the Act authorize an 
agency to dispense with normal notice and comment rulemaking procedures 
for good cause if the agency makes a finding that the notice and 
comment process is impracticable, unnecessary, or contrary to the 
public interest, and includes a statement of the finding and the 
reasons for it in the rule. In addition, section 553(d)(3) of the APA 
and section 1871(e)(1)(B)(ii) allow the agency to avoid the 30-day 
delay in effective date where such delay is contrary to the public 
interest and the agency includes in the rule a statement of the finding 
and the reasons for it. In our view, this correcting document does not 
constitute a rulemaking that would be subject to these requirements.
    This document merely corrects technical errors in the CY 2020 PFS 
final rule. The corrections contained in this document are consistent 
with, and do not make substantive changes to, the policies and payment 
methodologies that were proposed, subject to notice and comment 
procedures, and adopted in the CY 2020 PFS final rule. As a result, the 
corrections made through this correcting document are intended to 
resolve inadvertent errors so that the rule accurately reflects the 
policies adopted in the final rule. Even if this were a rulemaking to 
which the notice and comment and delayed effective date requirements 
applied, we find that there is good cause to waive such requirements. 
Undertaking further notice and comment procedures to incorporate the 
corrections in this document into the CY 2020 PFS final rule or 
delaying the effective date of the corrections would be contrary to the 
public interest because it is in the public interest to ensure that the 
rule accurately reflects our policies as of the date they take effect. 
Further, such procedures would be unnecessary because we are not making 
any substantive revisions to the final rule, but rather, we are simply 
correcting the Federal Register document to reflect the policies that 
we previously proposed, received public comment on, and subsequently 
finalized in the final rule. For these reasons, we believe there is 
good cause to waive the requirements for notice and comment and delay 
in effective date.

IV. Correction of Errors

    In FR Doc. 2019-24086 (84 FR 62568), published November 15, 2019, 
make the following corrections:

A. Correction of Errors in the Preamble

    1. On page 62568, in the second column, the first full paragraph is 
corrected to read:
    ``DATES:
    Effective date: These regulations are effective on January 1, 2020.
    Applicability date: The following provisions as described in 
section II.P. of this final rule, Payment for Evaluation and Management 
Services, are applicable beginning January 1, 2021: (1) Adoption of 
certain new coding, prefatory language, and interpretive guidance that 
has been approved by the American Medical Association/Common Procedural 
Terminology (AMA/CPT) Editorial Panel; (2) establishment of certain AMA 
Relative Value Scale Update Committee (RUC)-recommended work values for 
office/outpatient E/M visit codes; and (3) establishment and valuation 
of a single add-on code for visit complexity inherent to evaluation and 
management associated with medical care services that serve as the 
focal point for al needed health care services and/or with medical care 
services that are part of ongoing care related to a patient's single, 
serious, or complex chronic condition.''.
    2. On page 62699, second column, under the heading, ``7. Rural 
Health Clinics (RHCs) and Federally-Qualified Health Centers (FQHCs)'', 
first paragraph, lines 9 through 11, that reads ``health services, and 
we are allowing G0511 to also be billed when the requirements for PCM 
are met.'' is corrected to read ``health services.''.
    3. On page 62910, third column, second full paragraph, line 6, that 
reads ``(or payment models levels within a

[[Page 10]]

track)'' should read ``(or payment models within a track)''.
    4. On page 62932, second column, third full paragraph, lines 15 
through 17, that reads ``(a)(15); the lone amendment to Sec.  424.535 
is the addition of paragraph (a)(22).'' is corrected to read ``(a)(15); 
the only amendments to Sec.  424.535 are our previously mentioned 
revision to paragraph (a)(14) and the addition of paragraph (a)(22).''.
    5. On page 62972, third column, last paragraph, lines 20 through 
21, that reads ``Hospitalists, medical oncologists, and radiation 
specialties'' is corrected to read ``Hospitalists and radiation 
oncologists,''.
    6. On page 62973, first column, first partial paragraph, lines 4 
through 7, that reads ``Other oncology specialties, including 
hematology oncology, medical oncology, gynecological oncology, and 
rheumatology' is corrected to read ``Rheumatology and other oncology 
specialties, including hematology oncology, medical oncology, and 
gynecological oncology,''.

B. Correction of Errors in the Regulatory Text


Sec.  403.902  [Corrected]

0
1. On page 63185, in the third column, amendatory instruction 2.b. is 
corrected to read ``In the definition of ``Covered recipient'' by 
revising paragraph (1).

C. Correction of Errors in the Addenda

    1. On page 63205, the title ``TABLE Group A: New Quality Measures 
Finalized for the 2022 MIPS Payment Year and Future Years'' is 
corrected to read: ``TABLE Group A: New Quality Measures Finalized and 
Not Finalized for the 2022 MIPS Payment Year and Future Years''.
    2. On page 63212, the title ``TABLE Group AA: New Quality Measures 
Finalized for the 2023 MIPS Payment Year and Future Years'' is 
corrected to read: ``TABLE Group AA: New Quality Measure Not Finalized 
for the 2023 MIPS Payment Year and Future Years''.
    3. On page 63438, the last sentence of Table D.12 is corrected by 
replacing ``Q112'' with ``Q113''.
    4. On page 63516, the Activity ID entry ``IA_CC_18'' is corrected 
to read ``IA_CC_19''.
    5. On pages 63539 through 63563, the second occurrence of Appendix 
2 is removed.

    Dated: December 19, 2019.
Ann C. Agnew,
Executive Secretary to the Department, Department of Health and Human 
Services.
[FR Doc. 2019-28005 Filed 12-30-19; 4:15 pm]
BILLING CODE 4120-01-P